Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative (SECOND N0): Non-inferiority Phase III Trial

NCT05774483 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT05774483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05774483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative (SECOND N0): Non-inferiority Phase III Trial
Lead sponsor
Tata Memorial Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 16, 2025
Completion date
April 30, 2034
Enrollment
508 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mouth neoplasms, oral cancers, oral squamous cell carcinoma (oscc), oral squamous cell carcinomas, sentinel lymph node, sentinel lymph node biopsy, sentinel lymph node biopsy (slnb)